Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort Source: Eur Respir J 2013; 42: 636-646 Year: 2013
One-year exacerbation frequency and treatment in the ECLIPSE study cohort Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009
Heterogeneity in the clinical outcomes of COPD: lessons from the ECLIPSE study Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes Year: 2017
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020 Year: 2021
Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study Source: International Congress 2019 – Clinical implications of asthma management Year: 2019
Evaluation of asthma/COPD overlap within the ECLIPSE study Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015
A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017
External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020
Clinically important results of phenotyping and endotyping of COPD: the ECLIPSE study Source: Annual Congress 2012 - PG14 From phenotypes to endotypes of asthma and COPD Year: 2012
Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Fatty liver infiltration in patients with COPD. An ECLIPSE cohort study Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016
Evaluation of roflumilast in COPD patients in a real-world European setting: results from the PROFILE EU study Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017
Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016
Fatigue components in COPD patients and controls using the FACIT-F scale; data from ECLIPSE study Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011
Health status changes in COPD patients after real-life switch from tiotropium or salmeterol/fluticasone to indacaterol/glycopyrronium using the EQ-5D-3L instrument: results from the POWER study Source: International Congress 2018 – COPD management Year: 2018
Multicentre comparison of self-management in patients with COPD Source: ERJ Open Res, 7 (3) 00252-2021; 10.1183/23120541.00252-2021 Year: 2021
Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021
Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013
Estimation of a disease progression model for COPD using data from the ECLIPSE study Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013